EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex differences in amyloid PET in a large, real‐world sample from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Study

Maison Abu Raya iD, Ehud Zeltzer, Ganna Blazhenets, Daniel R Schonhaut, Isabel Elaine Allen, Maria C Carrillo, Constantine Gatsonis, Lucy Hanna, Bruce E Hillner, Leonardo Iaccarino, Andrew March, Nidhi S Mundada und 9 weitere

Alzheimer's & Dementia · 2025-05 · 21 (5)

DOI: 10.1002/alz.70304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.05.2025. Verfasst von Maison Abu Raya und 20 weiteren Autor:innen. Beteiligte Einrichtung: Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, Californi…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Dementia, Sex Characteristics, Brain. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American College of Radiology, Avid Radiopharmaceuticals Inc. (a wholly owned subsidiary of Eli Lilly and Company), Life Molecular Imaging (formerly Piramal Imaging).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We examined sex effects on amyloid positron emission tomography (PET) in a large cohort of patients evaluated for cognitive complaints in a “real‐world” specialty setting. METHODS We analyzed 10,361 amyloid PET scans (51% females) from the Imaging Dementia–Evidence for Amyloid Scanning Study. Amyloid positivity was defined by either local visual read or central PET processing and quantification (≥ 24.4 Centiloids). Sex differences were examined using multilinear regression and logistic regression adjusted for age, comorbidities, and other demographic and clinical covariates. RESULTS Females had higher rates of positive amyloid PET visual reads (63% vs. 59%, P < 0.001) and higher Centiloids (CLs; median 48.7 vs. 36.8, p < 0.001). On logistic regression, females had higher odds ratios (ORs) for positive amyloid PET (visual read OR 1.20, 95% confidence interval [CI]: 1.11–1.31; CL threshold–based OR 1.37, 95% CI: 1.26–1.49; both p < 0.001). DISCUSSION Females with cognitive impairment showed higher amyloid PET positivity and greater amyloid burden. Further research is needed to explore mechanisms and treatment implications. Highlights Females exhibited higher rates of amyloid positron emission tomography (PET) positivity and higher amyloid burden than males. These sex effects were found in patients with both mild cognitive impairment (MCI) and dementia. Females also had higher rates of dementia and amnestic MCI, while males had higher rates of non‐amnestic MCI and more cholinesterase inhibitor use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyDementiaSex CharacteristicsBrainAmyloidCognitive DysfunctionHumansFemaleMaleAgedAged, 80 and overSex FactorsCohort Studies

Stichwörter der Autor:innen

Alzheimer's diseaseCentiloidamyloiddementiamild cognitive impairmentpositron emission tomographysex differences

Substanzen

Amyloid

Autor:innen und Institutionen

  • Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
  • Global Brain Health Institute, University of California San Francisco, San Francisco, California, USA.
  • Medical & Scientific Relations Division, Alzheimer's Association, Chicago, Illinois, USA.
  • Department of Biostatistics, Brown University, Providence, Rhode Island, USA.
  • Center for Statistical Sciences, Brown University, Providence, Rhode Island, USA.
  • Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Maison Abu Raya, Gil D Rabinovici

Förderung

  • American College of Radiology
  • Avid Radiopharmaceuticals Inc. (a wholly owned subsidiary of Eli Lilly and Company)
  • Life Molecular Imaging (formerly Piramal Imaging)
  • General Electric Healthcare
  • Alzheimer's Association

Zitieren

APA

Abu Raya, M., Zeltzer, E., Blazhenets, G., Schonhaut, D. R., Allen, I. E., Carrillo, M. C., Gatsonis, C., Hanna, L., Hillner, B. E., Iaccarino, L., March, A., Mundada, N. S., Perez, J. M., Smith, K., Yballa, C., Siegel, B. A., Windon, C., Whitmer, R. A., Kaitlin, C., …, & Rabinovici, G. D. (2025). Sex differences in amyloid PET in a large, real‐world sample from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Study. Alzheimer's & Dementia, 21(5). https://doi.org/10.1002/alz.70304

Vancouver

Abu Raya M, Zeltzer E, Blazhenets G, Schonhaut DR, Allen IE, Carrillo MC, et al. Sex differences in amyloid PET in a large, real‐world sample from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Study. Alzheimer's & Dementia. 2025;21(5). doi:10.1002/alz.70304

BibTeX
@article{AbuRaya2025,
  author = {Abu Raya, Maison and Zeltzer, Ehud and Blazhenets, Ganna and Schonhaut, Daniel R and Allen, Isabel Elaine and Carrillo, Maria C and Gatsonis, Constantine and Hanna, Lucy and Hillner, Bruce E and Iaccarino, Leonardo and March, Andrew and Mundada, Nidhi S and Perez, Jhony Mejia and Smith, Karen and Yballa, Claire and Siegel, Barry A and Windon, Charles and Whitmer, Rachel A and Kaitlin, Casaletto and La Joie, Renaud and Rabinovici, Gil D},
  title = {Sex differences in amyloid PET in a large, real‐world sample from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {5},
  doi = {10.1002/alz.70304}
}
Kostenlos starten →